课题基金 / 基金详情

Chemical Agents That Affect Biomembrane Function

Chemical Agents That Affect Biomembrane Function
影响生物膜功能的化学试剂
批准号:
6891289
负责人:
BRADLEY D. SMITH
金额:
$26.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2007-04-30

项目摘要

项目成果

BRADLEY D. SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objectives are to synthesize and evaluate organic molecules that can affect dynamic membrane processes such as fusion, phospholipid flip-flop, pore formation and cell surface recognition. The research is conducted for two major reasons: (a) The studies provide useful insight into the supramolecular factors that control these biomedically important processes; (b) Organic compounds are produced that can be used as reagents in membrane biology research, diagnostic indicators of disease, or as pharmaceutical leads. The specific aims of this proposal are, 1: Develop a synthetic sensor for phosphatidylserine (PS) appearance on the surface of a cell which is a hallmark of cell apoptosis. Currently, dye-labeled Annexin V is used extensively as a PS-sensing reagent that detects apoptosis, but this protein-based detection method has a number of limitations. Parallel synthesis and screening methods will be used to prepare and identify a synthetic PS-sensor that can provide a quantitative measure of apoptotic index for heterogeneous samples such as blood, spleen, lymph nodes and bone marrow. This PS-sensor could then be used to develop a clinically useful method of measuring the efficacy of anticancer drugs in individual patients. 2: Develop a synthetic PS-scramblase as a new way to help the body eliminate pathogenic cells. Parallel synthesis and screening methods will be used to identify an organic compound that can scramble the distribution of PS across plasma membranes. It is hypothesized that an increase in the concentration of externalized PS will trigger cell clearance by phagocytosis. 3: A novel prodrug strategy will selectively deliver the apoptosisinducing compound described in aim 2 to prostate cancer cells. The prodrug is activated by the prostate specific membrane antigen (PSMA) that is present in elevated amounts on the surface of prostate tumor cells. 4: Test the hypothesis that phospholipids can adopt an extended conformation (the non-polar tails extend in opposite directions) during important dynamic membrane processes such as fusion, phospholipid flip-flop, pore formation and binding of peripheral proteins. The experimental approach is to compare the supramolecular properties of conformationally restricted polar lipids that are unable to adopt a fully extended conformation with more flexible analogues that can. If the extended conformation hypothesis is confirmed then it represents a new and very different view of phospholipid dynamics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Probes for Biomembrane Recognition
  • 批准号:
    10366056
  • 项目类别:
  • 资助金额:
    $39.29万
  • 财政年份:
    2020
  • 负责人:
    BRADLEY D. SMITH
  • 依托单位:
Molecular Probes for Biomembrane Recognition
  • 批准号:
    9927840
  • 项目类别:
  • 资助金额:
    $40.57万
  • 财政年份:
    2020
  • 负责人:
    BRADLEY D. SMITH
  • 依托单位:
Molecular Probes for Biomembrane Recognition
  • 批准号:
    10581635
  • 项目类别:
  • 资助金额:
    $39.29万
  • 财政年份:
    2020
  • 负责人:
    BRADLEY D. SMITH
  • 依托单位:
Molecular Probes for Biomembrane Recognition
  • 批准号:
    10116431
  • 项目类别:
  • 资助金额:
    $39.29万
  • 财政年份:
    2020
  • 负责人:
    BRADLEY D. SMITH
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: